PAK5 is a potential target in myelodysplastic syndrome through interacting with LMO2 and GATA1.
Sign Up to like & getrecommendations! Published in 2022 at "Cellular and molecular biology"
DOI: 10.14715/cmb/2022.68.9.12
Abstract: Myelodysplastic syndrome (MDS) is a neoplastic heterogeneous and pre-leukemic disease with poor clinical outcome due to the failure of current chemotherapeutic strategies to target leukemic stem cells. Recently, we find that p21-activated kinase 5 (PAK5)… read more here.
Keywords: pak5 potential; lmo2 gata1; gata1; pak5 ... See more keywords